Search Results - "Murray, G. I."

Refine Results
  1. 1

    The role of annexins in tumour development and progression by Mussunoor, S, Murray, GI

    Published in The Journal of pathology (01-10-2008)
    “…The annexins are a super‐family of closely related calcium and membrane‐binding proteins. They have a diverse range of cellular functions that include vesicle…”
    Get full text
    Journal Article
  2. 2

    Characterisation and protein expression profiling of annexins in colorectal cancer by Duncan, R, Carpenter, B, Main, L C, Telfer, C, Murray, G I

    Published in British journal of cancer (29-01-2008)
    “…The annexins are family of calcium-regulated phospholipid-binding proteins with diverse roles in cell biology. Individual annexins have been implicated in…”
    Get full text
    Journal Article
  3. 3

    Prognostic value of lymph node ratio and extramural vascular invasion on survival for patients undergoing curative colon cancer resection by Parnaby, C N, Scott, N W, Ramsay, G, MacKay, C, Samuel, L, Murray, G I, Loudon, M A

    Published in British journal of cancer (14-07-2015)
    “…Background: Increasing lymph node ratio (LNR) (ratio of metastatic lymph nodes to the total number of harvested lymph nodes) and extramural vascular invasion…”
    Get full text
    Journal Article
  4. 4

    Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer by CARPENTER, B, MCKAY, M, DUNDAS, S. R, LAWRIE, L. C, TELFER, C, MURRAY, G. I

    Published in British journal of cancer (09-10-2006)
    “…Heterogeneous ribonucleoprotein K (hnRNP K) is a member of the hnRNP family which has several different cellular roles including transcription, mRNA shuttling,…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis by Curran, S, Murray, G.I

    Published in European journal of cancer (1990) (01-08-2000)
    “…The matrix metalloproteinases (MMPs) are a family of proteolytic enzymes, whose physiological functions include tissue remodelling and embryogenesis. The…”
    Get full text
    Journal Article
  7. 7

    Expression of neutrophil gelatinase-associated lipocalin in colorectal neoplastic progression: a marker of malignant potential? by McLean, M H, Thomson, A J, Murray, G I, Fyfe, N, Hold, G L, El-Omar, E M

    Published in British journal of cancer (25-06-2013)
    “…Background: Neutrophil gelatinase-associated lipocalin (NGAL) has a diverse functional repertoire, involved in the innate immune response as well as cell…”
    Get full text
    Journal Article
  8. 8

    Matrix metalloproteinases in tumour invasion and metastasis by Curran, Stephanie, Murray, Graeme I.

    Published in The Journal of pathology (01-11-1999)
    “…The matrix metalloproteinases (MMPs) are a large family of proteolytic enzymes, which are involved in the degradation of many different components of the…”
    Get full text
    Journal Article
  9. 9

    Influence of HPV type on prognosis in patients diagnosed with invasive cervical cancer by Cuschieri, K., Brewster, D.H., Graham, C., Nicoll, S., Williams, A.R.W., Murray, G.I., Millan, D., Johannessen, I., Hardie, A., Cubie, H.A.

    Published in International journal of cancer (01-12-2014)
    “…While much is known about the influence of HPV type on the progression of pre‐invasive cervical lesions, the impact of HPV type on cervical cancer prognosis is…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases by McKay, J.A, Murray, L.J, Curran, S, Ross, V.G, Clark, C, Murray, G.I, Cassidy, J, McLeod, H.L

    Published in European journal of cancer (1990) (01-11-2002)
    “…Overexpression of the epidermal growth factor receptor (EGFR) often correlates with an aggressive tumour phenotype and poor prognosis. To examine the relevance…”
    Get full text
    Journal Article
  12. 12

    Tumour cytochrome P450 and drug activation by Patterson, L H, Murray, G I

    Published in Current pharmaceutical design (01-01-2002)
    “…The expression of drug metabolising cytochrome P450s (CYPs) notably 1A, 1B, 2C, 3A, 2D subfamily members have been identified in a wide range of human cancers…”
    Get more information
    Journal Article
  13. 13

    Liver fatty acid binding protein expression in colorectal neoplasia by LAWRIE, L. C, DUNDAS, S. R, CURRAN, S, MURRAY, G. I

    Published in British journal of cancer (17-05-2004)
    “…Liver fatty acid binding protein is a member of the fatty acid binding group of proteins that are involved in the intracellular transport of bioactive fatty…”
    Get full text
    Journal Article
  14. 14

    Characterization and over-expression of chaperonin t-complex proteins in colorectal cancer by Coghlin, C, Carpenter, B, Dundas, SR, Lawrie, LC, Telfer, C, Murray, GI

    Published in The Journal of pathology (01-11-2006)
    “…The chaperonins are key molecular complexes, which are essential in the folding of proteins to produce stable and functionally competent protein conformations…”
    Get full text
    Journal Article
  15. 15

    Cytochrome P450 CYP1B1 activity in renal cell carcinoma by MCFADYEN, M. C. E, MELVIN, W. T, MURRAY, G. I

    Published in British journal of cancer (31-08-2004)
    “…Renal cell carcinoma (RCC) is the most common malignancy of the kidney and has a poor prognosis due to its late presentation and resistance to current…”
    Get full text
    Journal Article
  16. 16

    Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer by Leeman, M F, McKay, J A, Murray, G I

    Published in Journal of clinical pathology (01-10-2002)
    “…Aims: The matrix metalloproteinases (MMPs) are a family of proteolytic enzymes collectively capable of degrading all extracellular matrix components, in…”
    Get full text
    Journal Article
  17. 17

    Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1 by Murray, G I, Melvin, W T, Greenlee, W F, Burke, M D

    “…Cytochrome P450 CYP1B1 is a relatively recently identified member of the CYP1 gene family. The purpose of this commentary is to review the regulatory…”
    Get full text
    Journal Article
  18. 18

    Matrix metalloproteinases and their inhibitors in gastric cancer by Murray, G I, Duncan, M E, Arbuckle, E, Melvin, W T, Fothergill, J E

    Published in Gut (01-12-1998)
    “…Background—The matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases (TIMPs) are strongly implicated in tumour invasion and…”
    Get full text
    Journal Article
  19. 19

    CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia by TAYEB, M. T, CLARK, C, HAITES, N. E, SHARP, L, MURRAY, G. I, MCLEOD, H. L

    Published in British journal of cancer (24-03-2003)
    “…Prostate cancer (PRCa) is one of the most common causes of cancer death in men and determinants of PRCa risk remain largely unidentified. Benign prostatic…”
    Get full text
    Journal Article
  20. 20

    Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer by MCFADYEN, M. C. E, CRUICKSHANK, M. E, MILLER, I. D, MCLEOD, H. L, MELVIN, W. T, HAITES, N. E, PARKIN, D, MURRAY, G. I

    Published in British journal of cancer (20-07-2001)
    “…Ovarian cancer is the most frequent cause of death from gynaecological malignancies world wide. Little improvement has been made in the long-term outcome of…”
    Get full text
    Journal Article